Skip to content
Screener

Pacific Biosciences of California PACB Q1 2025 earnings

Reported May 8, 2025 · Before market open

Revenue$37.2MBeat by $253.0K
EPS-$0.15Beat by $0.04
Revenue estimate$36.9M
EPS estimate-$0.19

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$43.8M
EPS estimate-$0.13

Financials

Q1 2025

Income statement

See full
Revenue$37.2M-4.3%
Gross profit-$1.4M-112%
Operating income-$428.9M-427%
Net income-$426.1M-445%
EPS (diluted)-$1.44-397%

Balance sheet

See full
Cash & equivalents$60.7M-23.5%
Total debt$52.9M+36.3%
Total equity$91.6M-85.9%
Total assets$860.8M-48.5%

Cash flow

See full
Operating cash flow-$44.1M+41.8%
CapEx$1.4M-64.2%
Free cash flow-$45.4M+42.9%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$351.47M-64.9%
Enterprise value$343.63M-64.2%
P/S2.3×-2.7×

Profitability

See full
Gross margin16.2%-10.9pp
Operating margin-539.4%-945pp
Net margin-433.3%-902pp
FCF margin-116.9%-6.6pp

Returns & leverage

See full
Return on equity-178.3%-266pp
Debt / equity0.6×+0.5×
Current ratio6.7×-2.6×

Segments

By geography

See full
Americas$16.3M-7.8%
Asia-Pacific$11.6M-9.1%
Europe, Middle East and Africa$9.2M+10.6%

By product

See full
Consumable revenue$20.1M+25.7%
Instrument revenue$11.0M-42.1%
Service and other revenue$6.0M+58.9%

By segment

See full
Reportable Segment$37.2M-4.3%

FAQ

When did Pacific Biosciences of California report Q1 2025 earnings?
Pacific Biosciences of California (PACB) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Pacific Biosciences of California's Q1 2025 revenue and EPS?
Pacific Biosciences of California reported revenue of $37.2M and eps of $-0.15 for Q1 2025.
Did Pacific Biosciences of California beat estimates in Q1 2025?
Revenue beat the consensus estimate of $36.9M by $253.0K. EPS beat the consensus estimate of $-0.19 by $0.04.
How did Pacific Biosciences of California's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.3% from $38.8M a year earlier and eps grew 48.3% from $-0.29.
Where can I find Pacific Biosciences of California's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001299130-25-000099) and the 10-Q periodic report (0001299130-25-000102) directly on SEC EDGAR. The filing index links above go to sec.gov.